Neuronostics - About the company
Neuronostics is a seed company based in Exeter (United Kingdom), founded in 2018 by John Terry. It operates as a Provider of neuro seizure assessment software for doctors. Neuronostics has raised $3.08M in funding from QantX and Ascension. The company has 138 active competitors, including 54 funded and 5 that have exited. Its top competitors include companies like Ceribell, Empatica and Cumulus Neuro.
Company Details
Neuronostics provides neuro seizure assessment software for doctors. The technology BioEP is a patented seizure risk score calculated from routine EEG recordings that can enable early diagnosis and prognosis of epilepsy.
- Website
- www.neuronostics.com/
- Email ID
- *****@neuronostics.com
- Phone Number
- +44 **********
- Registered Address
- The Innovation Centre University Of Exeter, Rennes Drive, Exeter, England, EX4 4RN
Key Metrics
Founded Year
2018
Location
Exeter, United Kingdom
Stage
Seed
Total Funding
$3.08M in 4 rounds
Latest Funding Round
Ranked
24th among 138 active competitors
Annual Revenue
£0 - £1M as on Dec 31, 2024
Employee Count
20 as on May 31, 2026
Legal entities associated with Neuronostics
Neuronostics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
NEURONOSTICS LIMITED CIN: 11123728 , United Kingdom, Active | Dec 21, 2017 | $0 - $1M (As on Dec 31, 2024) | 13 (As on Dec 31, 2024) |
Sign up to download Neuronostics' company profile
Neuronostics's funding and investors
Neuronostics has raised a total funding of $3.08M over 4 rounds. Its first funding round was on May 22, 2020. Its latest funding round was a Seed round on Apr 08, 2024 for $*****. 5 investors participated in its latest round. Neuronostics has 8 institutional investors and 10 angel investors.
Here is the list of recent funding rounds of Neuronostics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 08, 2024 | 7422975 | Seed | 4498267 | 9172637 | 8238894 | 9879643 |
Apr 06, 2021 | 4792453 | Seed | 1426797 | 4096365 | 1886237 | 6947042 |
Sep 11, 2020 | 3680502 | Seed | 1341535 | 6405049 | 2951473 | 8367782 |
Access funding benchmarks and valuations. Sign up today!View details of Neuronostics's funding rounds and investors
Neuronostics' founders and board of directors
Founder? Claim ProfileThe founders of Neuronostics is John Terry.
Here are the details of Neuronostics' key team members:
- John Terry: Co-Founder of Neuronostics.
View details of Neuronostics's Founder profiles and Board Members
Neuronostics' employee count trend
Neuronostics has 20 employees as of May 26. Here is Neuronostics's employee count trend over the years:
Uncover Neuronostics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Neuronostics's Competitors and alternates
Top competitors of Neuronostics include Ceribell, Empatica and Cumulus Neuro. Here is the list of Top 10 competitors of Neuronostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Ceribell 2014, Mountain View (United States), Public | EEG system for the diagnosis of seizures | $188M | 69/100 | |
2nd | Developer of a wrist band to monitor physiological signals | $30.9M | 67/100 | ||
3rd |  Cumulus Neuro 2015, Belfast (United Kingdom), Series A | AI and cloud-based brain physiology analysis tool for clinical trials | $19.6M | 61/100 | |
4th |  Cortical Labs 2019, Melbourne (Australia), Series A | Manufacturer of AI-powered biochips | $11.6M | 60/100 | |
5th | Beacon Biosignals 2019, Boston (United States), Series B | AI-based EEG analysis and diagnosis platform for healthcare providers | $141M | 58/100 | |
6th |  BrainScope 2006, Bethesda (United States), Series B | Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds | $62.2M | 58/100 | |
7th | BrainCo 2015, Somerville (United States), Series A | Provider of a prosthetic hand and EEG headband for brain signal | $292M | 58/100 | |
8th | Spark Biomedical 2018, Houston (United States), Series A | Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment | $31.2M | 57/100 | |
9th | Emotiv 2011, San Francisco (United States), Seed | Manufacturer of wireless EEG headsets and software solutions | $7.41M | 56/100 | |
10th | Cercare Medical 2013, Aarhus (Denmark), Series A | Provider of diagnostic software for acute stroke management | $7.82M | 54/100 | |
24th |  Neuronostics 2018, Exeter (United Kingdom), Seed | Provider of neuro seizure assessment software for doctors | $3.08M | 40/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Neuronostics's competitors? Click here to see the top ones
Neuronostics's Investments and acquisitions
Neuronostics has made no investments or acquisitions yet.
Reports related to Neuronostics
Here is the latest report on Neuronostics's sector:
News related to Neuronostics
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Neuronostics
Explore our recently published companies
- Immediate Edge - London based, 2019 founded, Unfunded company
- Immediate Edge - Unfunded company
- ActiveKite - Coimbatore based, 2016 founded, Unfunded company
- Omee - Unfunded company
- Feria Virtual - Estepona based, 2014 founded, Unfunded company
- Dawks - 2023 founded, Unfunded company
